Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer

Purpose: This study aimed to examine the effect of radiation esophagitis (RE) and the dynamics of RE on subsequent survival in non-small cell lung cancer (NSCLC) patients who underwent radiotherapy. Experimental Design: Patients with NSCLC treated with fractionated thoracic radiotherapy enrolled in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hao Yu, Ka-On Lam, Michael D. Green, Huanmei Wu, Li Yang, Weili Wang, Jianyue Jin, Chen Hu, Yang Wang, Shruti Jolly, Feng-Ming (Spring) Kong
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/9319e04b9edc47d0968fd45d7f5dcdbb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9319e04b9edc47d0968fd45d7f5dcdbb
record_format dspace
spelling oai:doaj.org-article:9319e04b9edc47d0968fd45d7f5dcdbb2021-12-01T05:06:36ZSignificance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer2667-005410.1016/j.jncc.2021.02.003https://doaj.org/article/9319e04b9edc47d0968fd45d7f5dcdbb2021-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667005421000077https://doaj.org/toc/2667-0054Purpose: This study aimed to examine the effect of radiation esophagitis (RE) and the dynamics of RE on subsequent survival in non-small cell lung cancer (NSCLC) patients who underwent radiotherapy. Experimental Design: Patients with NSCLC treated with fractionated thoracic radiotherapy enrolled in prospective trials were eligible. RE was graded prospectively according to Common Terminology Criteria for Adverse Events (CTCAE) v3.0 per protocol requirement weekly during-RT and 1 month after RT. This study applied conditional survival assessment which has advantage over traditional survival analysis as it assesses the survival from the event instead of from the baseline. P-value less than 0.05 was considered to be significant. The primary endpoint is overall survival. Results: A total of 177 patients were eligible, with a median follow-up of 5 years. The presence of RE, the maximum RE grade, the evolution of RE and the onset timing of RE events were all correlated with subsequent survival. At all conditional time points, patients first presented with RE grade1 (initial RE1) had significant inferior subsequent survival (multivariable HRs median: 1.63, all P-values<0.05); meanwhile those with RE progressed had significant inferior subsequent survival than those never develop RE (multivariable HRs median: 2.08, all P-values<0.05). Multivariable Cox proportional-hazards analysis showed significantly higher C-indexes for models with inclusion of RE events than those without (all P-values<0.05). Conclusion: This study comprehensively evaluated the impact of RE with conditional survival assessment and demonstrated that RE is associated with inferior survival in NSCLC patients treated with RT.Hao YuKa-On LamMichael D. GreenHuanmei WuLi YangWeili WangJianyue JinChen HuYang WangShruti JollyFeng-Ming (Spring) KongElsevierarticleRadiotherapyRadiation esophagitisConditional survivalNon-small cell lung cancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal of the National Cancer Center, Vol 1, Iss 2, Pp 31-38 (2021)
institution DOAJ
collection DOAJ
language EN
topic Radiotherapy
Radiation esophagitis
Conditional survival
Non-small cell lung cancer
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Radiotherapy
Radiation esophagitis
Conditional survival
Non-small cell lung cancer
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Hao Yu
Ka-On Lam
Michael D. Green
Huanmei Wu
Li Yang
Weili Wang
Jianyue Jin
Chen Hu
Yang Wang
Shruti Jolly
Feng-Ming (Spring) Kong
Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer
description Purpose: This study aimed to examine the effect of radiation esophagitis (RE) and the dynamics of RE on subsequent survival in non-small cell lung cancer (NSCLC) patients who underwent radiotherapy. Experimental Design: Patients with NSCLC treated with fractionated thoracic radiotherapy enrolled in prospective trials were eligible. RE was graded prospectively according to Common Terminology Criteria for Adverse Events (CTCAE) v3.0 per protocol requirement weekly during-RT and 1 month after RT. This study applied conditional survival assessment which has advantage over traditional survival analysis as it assesses the survival from the event instead of from the baseline. P-value less than 0.05 was considered to be significant. The primary endpoint is overall survival. Results: A total of 177 patients were eligible, with a median follow-up of 5 years. The presence of RE, the maximum RE grade, the evolution of RE and the onset timing of RE events were all correlated with subsequent survival. At all conditional time points, patients first presented with RE grade1 (initial RE1) had significant inferior subsequent survival (multivariable HRs median: 1.63, all P-values<0.05); meanwhile those with RE progressed had significant inferior subsequent survival than those never develop RE (multivariable HRs median: 2.08, all P-values<0.05). Multivariable Cox proportional-hazards analysis showed significantly higher C-indexes for models with inclusion of RE events than those without (all P-values<0.05). Conclusion: This study comprehensively evaluated the impact of RE with conditional survival assessment and demonstrated that RE is associated with inferior survival in NSCLC patients treated with RT.
format article
author Hao Yu
Ka-On Lam
Michael D. Green
Huanmei Wu
Li Yang
Weili Wang
Jianyue Jin
Chen Hu
Yang Wang
Shruti Jolly
Feng-Ming (Spring) Kong
author_facet Hao Yu
Ka-On Lam
Michael D. Green
Huanmei Wu
Li Yang
Weili Wang
Jianyue Jin
Chen Hu
Yang Wang
Shruti Jolly
Feng-Ming (Spring) Kong
author_sort Hao Yu
title Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer
title_short Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer
title_full Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer
title_fullStr Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer
title_full_unstemmed Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer
title_sort significance of radiation esophagitis: conditional survival assessment in patients with non-small cell lung cancer
publisher Elsevier
publishDate 2021
url https://doaj.org/article/9319e04b9edc47d0968fd45d7f5dcdbb
work_keys_str_mv AT haoyu significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT kaonlam significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT michaeldgreen significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT huanmeiwu significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT liyang significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT weiliwang significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT jianyuejin significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT chenhu significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT yangwang significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT shrutijolly significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
AT fengmingspringkong significanceofradiationesophagitisconditionalsurvivalassessmentinpatientswithnonsmallcelllungcancer
_version_ 1718405556250607616